Results 221 to 230 of about 846,625 (333)
Nanoformulated Diacerein Alleviates Hyperlipidemia via Gut Microbiota Modulation In Vivo
A nanoformulation of diacerein (Nano‐DIA) was fabricated with carboxymethyl cellulose, achieving enhanced solubility and rapid dissolution for alternative anti‐hyperlipidemia therapeutics. Mechanistic studies revealed its in vivo lipid‐lowering efficacy is through metabolite‐mediated and microbiota‐dependent manner, highlighting its dual action on host
Zheng Peng +8 more
wiley +1 more source
Big data dimensionality reduction-based supervised machine learning algorithms for NASH diagnosis. [PDF]
Tutsoy O, Ozturk HA, Sumbul HE.
europepmc +1 more source
Personalized Differential Privacy for Ridge Regression Under Output Perturbation
ABSTRACT The increased application of machine learning (ML) in sensitive domains requires protecting the training data through privacy frameworks, such as differential privacy (DP). Traditional DP enforces a uniform privacy level ε$$ \varepsilon $$, which bounds the maximum privacy loss that each data point in the dataset is allowed to incur.
Krishna Acharya +3 more
wiley +1 more source
The Construction and Performance Evaluation of a Risk Prediction Model for Nonalcoholic Steatohepatitis Based on Serological Markers. [PDF]
Huang D, Zhang W, Fang Y, Liu T, Zhou D.
europepmc +1 more source
From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
A. Gastaldelli, K. Cusi
semanticscholar +1 more source
Recurrent Jejunal Diverticulitis: A Rare Cause of Acute Abdomen. [PDF]
Al-Obaidi O, Cheng S, Nash E.
europepmc +1 more source
Liver cancer remains a leading global health threat, imposing a substantial and growing burden of disease and disability. This study explores the epidemiologic landscape of liver cancer worldwide and within China over recent decade using Global Burden of Disease database 2021 study.
Jiaqi Ruan, Hangkai Huang, Chengfu Xu
wiley +1 more source
Exploring the potential mechanisms of OSBPL3 in metabolic dysfunction-associated steatotic liver disease by integrating bulk and single-cell RNA sequencing data. [PDF]
Wang Q +8 more
europepmc +1 more source
Hepatic fibrosis and metabolic syndrome are more prevalent in PsA patients treated with methotrexate, compared to RA patients. Metabolic syndrome is associated with the risk of hepatic fibrosis in patients diagnosed with PsA and RA even after adjustment forcumulative methotrexate exposure.
Ratchaya Lertnawapan +3 more
wiley +1 more source

